Agilent Technologies Inc (A)

Currency in USD
128.75
+0.27(+0.21%)
Closed·
128.750.00(0.00%)
·
A Scorecard
Full Analysis
Management has been aggressively buying back shares
A is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
128.39131.00
52 wk Range
96.43153.84
Key Statistics
Prev. Close
128.48
Open
128.72
Day's Range
128.39-131
52 wk Range
96.43-153.84
Volume
1.63M
Average Volume (3m)
1.73M
1-Year Change
-6.95%
Book Value / Share
22.42
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
A Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
138.17
Upside
+7.31%
Members' Sentiments
Bearish
Bullish
ProTips
10 analysts have revised their earnings downwards for the upcoming period
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Agilent Technologies Inc Company Profile

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. This segment also offers GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies. The Diagnostics and Genomics segment provides genomics, contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses; and cell analysis plate based assays, flow cytometers, real-time cell analyzers, cell imaging systems, microplate readers, and related consumables. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Agilent Technologies Inc SWOT Analysis


Market Resilience
Agilent demonstrates solid performance amidst challenges, with emerging signs of demand recovery signaling potential industry upturn
Strategic Expansion
Delve into Agilent's $925 million acquisition of Biovectra, bolstering its position in the CDMO sector and enhancing capabilities in cutting-edge areas
Global Headwinds
Uncover the complexities Agilent faces in the Chinese market and pharmaceutical segment, impacting its near-term growth prospects
Future Trajectory
Explore analyst perspectives on Agilent's outlook, with price targets ranging from $125 to $135, reflecting evolving perceptions in a dynamic market
Read full SWOT analysis

Agilent Technologies Inc Earnings Call Summary for Q3/2025

  • Q3 revenue beat forecast at $1.74B, EPS met expectations at $1.37. Full-year revenue guidance raised to $6.91-$6.93B.
  • Core revenue growth strong at 6.1%. New platforms like nuuLLC and Pro IQ LC MS systems bolstered market position.
  • Company implemented operational changes, reducing management layers by 15% to improve efficiency.
  • Q4 revenue projected at $1.82-$1.84B with core growth of 4.8-6%. Full-year EPS guidance set at $5.56-$5.59.
  • Tariff costs estimated at $70M for H2, potentially impacting margins. Market volatility and supply chain disruptions remain challenges.
Last Updated: 27/08/2025, 22:52
Read Full Transcript

Compare A to Peers and Sector

Metrics to compare
A
Peers
Sector
Relationship
P/E Ratio
29.9x13.0x−0.6x
PEG Ratio
−2.710.180.00
Price/Book
5.7x1.9x2.6x
Price / LTM Sales
5.4x4.2x3.3x
Upside (Analyst Target)
8.7%31.9%37.8%
Fair Value Upside
Unlock9.4%4.3%Unlock

Analyst Ratings

8 Buy
10 Hold
0 Sell
Ratings:
18 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 138.17
(+7.31% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 4.28%
Dividend Yield
0.77%
Industry Median 1.33%
Annualised payout
0.99
Paid quarterly
5-Years Growth
+6.84%
Growth Streak

Earnings

Latest Release
Aug 27, 2025
EPS / Forecast
1.37 / 1.37
Revenue / Forecast
1.74B / 1.67B
EPS Revisions
Last 90 days

A Income Statement

People Also Watch

FAQ

What Stock Exchange Does Agilent Technologies Trade On?

Agilent Technologies is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Agilent Technologies?

The stock symbol for Agilent Technologies is "A."

What Is the Agilent Technologies Market Cap?

As of today, Agilent Technologies market cap is 36.52B.

What Is Agilent Technologies's Earnings Per Share (TTM)?

The Agilent Technologies EPS (TTM) is 4.28.

When Is the Next Agilent Technologies Earnings Date?

Agilent Technologies will release its next earnings report on 30 Nov 2025.

From a Technical Analysis Perspective, Is A a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Agilent Technologies Stock Split?

Agilent Technologies has split 0 times.

How Many Employees Does Agilent Technologies Have?

Agilent Technologies has 18000 employees.

What is the current trading status of Agilent Technologies (A)?

As of 06 Sept 2025, Agilent Technologies (A) is trading at a price of 128.75, with a previous close of 128.48. The stock has fluctuated within a day range of 128.39 to 131.00, while its 52-week range spans from 96.43 to 153.84.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.